Investor FAQs
They are located at 139 Main Street, Cambridge, MA 02124, United States.
The Company completed its IPO in July 2020.
iTeos is traded on the NASDAQ Global Market under the ticker ITOS.
Computershare
web.queries@computershare.com
1-800-736-3001, option 1 (U.S.)
1-781-575-3100, option 1 (non-U.S.)
Should you have questions about your shares, please contact our transfer agent, listed above. For all other investor inquiries, please contact IR@iteostherapeutics.com
The Company does not currently have a direct stock purchase plan. The Company’s common stock can be purchased by contacting a securities broker of your choice.
Goodwin Procter LLP and DELOITTE
Corporate news can be found in News & Events section of our Investors webpage. Quarterly and annual reports, as well as other SEC filings, can be found in the Financials section of our Investors webpage or directly from the SEC at www.sec.gov.
The Company’s annual report on Form 10K can be found in the Financials section of our Investors webpage or directly from the SEC at www.sec.gov.
Please contact IR@iteostherapeutics.com
Our current analyst coverage can be found in the Stock Information section of our Investors webpage.
The Company’s annual report on Form 10K can be found in the Financials section of our Investors webpage or directly from the SEC at www.sec.gov.
The date and location of the next annual meeting will be communicated prior to the meeting date.